Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David H Abramson

Showing results (1-10 of 345) with videos related to

Pageof 35
Sort By:
Ophthalmic Genetics|April 6, 2022
Cell Free DNA (cfDNA) in the Blood of Retinoblastoma Patients The Robert M. Ellsworth LectureDavid H Abramson
The British Journal of Ophthalmology|April 29, 2010
Super selective ophthalmic artery delivery of chemotherapy for intraocular retinoblastoma: 'chemosurgery' the first Stallard lectureDavid H Abramson
American Journal of Ophthalmology|April 25, 2007
Pediatric ophthalmic computed tomographic scanning and associated cancer riskDavid H Abramson
Ophthalmic Genetics|September 4, 2024
What have we learned about intraarterial chemotherapy (Ophthalmic Artery Chemosurgery) for retinoblastoma in the past 18 years? The third A. Linn Murphree LectureDavid H Abramson
Investigative Ophthalmology & Visual Science|July 27, 2005
Retinoblastoma in the 20th century: past success and future challenges the Weisenfeld lectureDavid H Abramson
Archives of Ophthalmology (Chicago, Ill. : 1960)|October 13, 2005
Growing melanocytic tumor is not always cancerDavid H Abramson
Archives of Ophthalmology (Chicago, Ill. : 1960)|January 12, 2005
Periocular chemotherapy for retinoblastoma: success with problems?David H Abramson
Archives of Ophthalmology (Chicago, Ill. : 1960)|November 16, 2011
Chemosurgery for retinoblastoma: what we know after 5 yearsDavid H Abramson
Ophthalmology|August 26, 2018
Re: Skalet et al.: Screening children at risk for retinoblastoma: consensus report from the American Association of Ophthalmic Oncologists and Pathologists (Ophthalmology. 2018;125:453-458)David H Abramson
Ophthalmic Genetics|March 30, 2023
Ten things you learned in your residency about retinoblastoma that have changed the 2023 Victor T. Curtin LectureDavid H Abramson
Pageof 35

Showing results (1-10 of 345) with videos related to

Sort By:
Pageof 35
Ophthalmic Genetics|April 6, 2022
Cell Free DNA (cfDNA) in the Blood of Retinoblastoma Patients The Robert M. Ellsworth LectureDavid H Abramson
The British Journal of Ophthalmology|April 29, 2010
Super selective ophthalmic artery delivery of chemotherapy for intraocular retinoblastoma: 'chemosurgery' the first Stallard lectureDavid H Abramson
American Journal of Ophthalmology|April 25, 2007
Pediatric ophthalmic computed tomographic scanning and associated cancer riskDavid H Abramson
Ophthalmic Genetics|September 4, 2024
What have we learned about intraarterial chemotherapy (Ophthalmic Artery Chemosurgery) for retinoblastoma in the past 18 years? The third A. Linn Murphree LectureDavid H Abramson
Investigative Ophthalmology & Visual Science|July 27, 2005
Retinoblastoma in the 20th century: past success and future challenges the Weisenfeld lectureDavid H Abramson
Archives of Ophthalmology (Chicago, Ill. : 1960)|October 13, 2005
Growing melanocytic tumor is not always cancerDavid H Abramson
Archives of Ophthalmology (Chicago, Ill. : 1960)|January 12, 2005
Periocular chemotherapy for retinoblastoma: success with problems?David H Abramson
Archives of Ophthalmology (Chicago, Ill. : 1960)|November 16, 2011
Chemosurgery for retinoblastoma: what we know after 5 yearsDavid H Abramson
Ophthalmology|August 26, 2018
Re: Skalet et al.: Screening children at risk for retinoblastoma: consensus report from the American Association of Ophthalmic Oncologists and Pathologists (Ophthalmology. 2018;125:453-458)David H Abramson
Ophthalmic Genetics|March 30, 2023
Ten things you learned in your residency about retinoblastoma that have changed the 2023 Victor T. Curtin LectureDavid H Abramson
Pageof 35